As one of the miR-183-5p targets is heme oxygenase-1 (HO-1) (a molecule reported to exacerbate ICH brain injury), the authors investigated the association between agomir-183-5p and antagomir-183-5p injections, HO-1 levels, and cerebral injury. Here, HMOX1 is linked to injury.